Decoding the Hidden Language of Cellular Turnover
Cellular turnover is a central event in health and disease, impacting nearly every cell in the body and occurring more than 30 billion times per hour. Inzen Therapeutics is pioneering a novel class of medicines based on manipulating cellular turnover, and its consequences, for the treatment of cancer, immune and fibrotic diseases, and regenerative processes.
Inzen Therapeutics was founded by Flagship Pioneering, a life sciences innovation enterprise dedicated to the origination and development of first-in-category life sciences companies through their Flagship Labs innovation foundry.
Inzen is seeking exceptional and visionary scientists to join our team. We currently have openings in the following areas: